CA967163A - Benzylimidazolidinones - Google Patents

Benzylimidazolidinones

Info

Publication number
CA967163A
CA967163A CA106,142A CA106142A CA967163A CA 967163 A CA967163 A CA 967163A CA 106142 A CA106142 A CA 106142A CA 967163 A CA967163 A CA 967163A
Authority
CA
Canada
Prior art keywords
benzylimidazolidinones
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA106,142A
Other languages
English (en)
Other versions
CA106142S (en
Inventor
Max Hoffer
Vsevolod Gruenman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of CA967163A publication Critical patent/CA967163A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/52—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
    • C07C47/575—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CA106,142A 1970-02-24 1971-02-24 Benzylimidazolidinones Expired CA967163A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1376970A 1970-02-24 1970-02-24

Publications (1)

Publication Number Publication Date
CA967163A true CA967163A (en) 1975-05-06

Family

ID=21761656

Family Applications (1)

Application Number Title Priority Date Filing Date
CA106,142A Expired CA967163A (en) 1970-02-24 1971-02-24 Benzylimidazolidinones

Country Status (18)

Country Link
US (1) US3636039A (pm)
JP (1) JPS5421338B1 (pm)
BE (1) BE763298A (pm)
BR (1) BR7101125D0 (pm)
CA (1) CA967163A (pm)
CH (2) CH567482A5 (pm)
DE (1) DE2108438C2 (pm)
DK (2) DK134601B (pm)
FI (1) FI54919C (pm)
FR (1) FR2081537B1 (pm)
GB (1) GB1292768A (pm)
IE (1) IE35283B1 (pm)
IL (1) IL36237A (pm)
NL (1) NL171446C (pm)
NO (1) NO130680C (pm)
SE (1) SE369190B (pm)
YU (1) YU34407B (pm)
ZA (1) ZA711077B (pm)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3932452A (en) * 1975-02-07 1976-01-13 Morton-Norwich Products, Inc. 1-Arylmethyl-2-imidazolidinones
US3966758A (en) * 1975-06-16 1976-06-29 Morton-Norwich Products, Inc. Anti-inflammatory 1-(substituted benzyl)-2-imidazolidinones
US4063022A (en) * 1976-11-22 1977-12-13 Morton-Norwich Products, Inc. Antisecretory 2-imidazolidinones
HU179019B (en) * 1978-11-01 1982-08-28 Gyogyszekutato Intezet Process for preparing 4-//3,4-dialkoxy-phenyl/-alkyl/- 2imidazolidinone derivatives
CA1188616A (en) * 1981-06-11 1985-06-11 Hoffmann-La Roche Limited Pharmaceutical preparations
FI875724L (fi) * 1986-04-29 1987-12-28 Pfizer Av kalcium oberoende camp fosfodiesteras-inhibitordepressant.
US5459145A (en) * 1988-01-19 1995-10-17 Pfizer Inc. Calcium independent camp phosphodiesterase inhibitor antidepressant
US5395935A (en) * 1992-05-08 1995-03-07 Pfizer Inc. Endo-bicyclo[2.2.1]heptan-2-ol and derived pharmaceutical agents
GB9312853D0 (en) * 1993-06-22 1993-08-04 Euro Celtique Sa Chemical compounds
US5591776A (en) * 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
US5922751A (en) * 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
US6025361A (en) * 1994-12-13 2000-02-15 Euro-Celtique, S.A. Trisubstituted thioxanthines
EP0799040B1 (en) * 1994-12-13 2003-08-20 Euroceltique S.A. Trisubstituted thioxanthines
WO1996018399A1 (en) * 1994-12-13 1996-06-20 Euro-Celtique, S.A. Aryl thioxanthines
US6166041A (en) * 1995-10-11 2000-12-26 Euro-Celtique, S.A. 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
US6075016A (en) * 1996-04-10 2000-06-13 Euro-Celtique S.A. 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
US5864037A (en) * 1996-06-06 1999-01-26 Euro-Celtique, S.A. Methods for the synthesis of chemical compounds having PDE-IV inhibitory activity
US5744473A (en) * 1996-09-16 1998-04-28 Euro-Celtique, S.A. PDE IV inhibitors: "bis-compounds"
EP1265861A2 (en) 2000-03-16 2002-12-18 Inflazyme Pharmaceuticals, Ltd. Benzylated pde4 inhibitors
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
CN103601792B (zh) 2007-06-04 2016-06-29 协同医药品公司 有效用于胃肠功能紊乱、炎症、癌症和其他疾病治疗的鸟苷酸环化酶激动剂
CA2726917C (en) 2008-06-04 2018-06-26 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP2321341B1 (en) 2008-07-16 2017-02-22 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CN108676076A (zh) 2011-03-01 2018-10-19 辛纳吉制药公司 制备鸟苷酸环化酶c激动剂的方法
HK1218629A1 (zh) 2013-02-25 2017-03-03 Bausch Health Ireland Limited 用於结肠清洁的鸟苷酸环化酶受体激动剂
CA2905438A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
US9486494B2 (en) 2013-03-15 2016-11-08 Synergy Pharmaceuticals, Inc. Compositions useful for the treatment of gastrointestinal disorders
SI3004138T1 (sl) 2013-06-05 2024-07-31 Bausch Health Ireland Limited Ultra čisti agonisti gvanilat ciklaze C, postopek za njihovo pripravo in uporabo
MX375926B (es) 2013-08-09 2025-03-07 Ardelyx Inc Compuestos y metodos para inhibir el transporte de fosfato.
EP3972599A1 (en) 2019-05-21 2022-03-30 Ardelyx, Inc. Combination for lowering serum phosphate in a patient

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH518285A (de) * 1968-05-01 1972-01-31 Hoffmann La Roche Verfahren zur Herstellung von neuen substituierten Benzylimidazolidinonen

Also Published As

Publication number Publication date
BE763298A (fr) 1971-08-23
DE2108438C2 (de) 1987-02-05
YU43971A (en) 1978-12-31
NL7102324A (pm) 1971-08-26
FI54919B (fi) 1978-12-29
IL36237A (en) 1974-11-29
NL171446B (nl) 1982-11-01
SE369190B (pm) 1974-08-12
ZA711077B (en) 1971-10-27
DK570075A (da) 1975-12-15
YU34407B (en) 1979-07-10
CH567483A5 (pm) 1975-10-15
IL36237A0 (en) 1971-04-28
IE35283L (en) 1971-08-24
IE35283B1 (en) 1976-01-07
NO130680C (pm) 1975-01-22
DK134601B (da) 1976-12-06
CH567482A5 (pm) 1975-10-15
FI54919C (fi) 1979-04-10
US3636039A (en) 1972-01-18
NL171446C (nl) 1983-04-05
JPS5421338B1 (pm) 1979-07-30
DE2108438A1 (de) 1971-09-09
DK134601C (pm) 1977-05-16
BR7101125D0 (pt) 1973-04-26
FR2081537A1 (pm) 1971-12-03
NO130680B (pm) 1974-10-14
GB1292768A (en) 1972-10-11
FR2081537B1 (pm) 1974-08-23

Similar Documents

Publication Publication Date Title
CA967163A (en) Benzylimidazolidinones
AU3684371A (en) 2-aminomethyl-4-6-dihalophenuls
AU3109571A (en) Toaster-oven
AU3557171A (en) Squeeze-mop
AU3418271A (en) 1-phenoxy-2-hydroxy-3-hydroxyalkyl-aminopropanes
AU3272071A (en) 1-nitrosopyrrolidines
AU3238671A (en) Carbamoyloxoimino-thiazolidinones
CA941954A (en) Transducteurs electroacoustiques multimoteurs
AU3314071A (en) N-THIENYLALKYL-b-ALKOXY-TRIFUOROMETHYL-PHENALKYLAMINES
AU3203471A (en) Imino-benzyl-pyrazoles
AU3515771A (en) Mast-holder
AU3380771A (en) Benzodioxanes
AU2940371A (en) 6-deoxy-5-oxytetracycline-5-esters
AU1278170A (en) Hydro-propeller
AU3186471A (en) Handstamps
AU1795470A (en) O-alkyl-o-phenyl-s-alkoxyethyl-phosphoro-thiolates
AU2656971A (en) Heat-energy-system
AU1746970A (en) Automatch
AU3058871A (en) 2-nitro-benzofurans
AU2645971A (en) 5-azapyrimidine-nucleosides
AU2642271A (en) Imidazolribosylcyclophosphate
AU3081971A (en) Comminutor-mixer
AU2766171A (en) Sample-and-hold-circuit
AU3128471A (en) 18-METHYL-17a-ETHINYL-TESTOSTERON-ESTER
AU1724570A (en) Novel-3-methyl-2 quinoxalinecarboxamide-n-oxides